Who are Omass's investors?

Omass's investors include GV (Google Ventures), Oxford Science Enterprises, Sanofi Ventures, Syncona, Northpond Ventures.

Where is Omass headquartered?

Omass is headquartered in Oxford, GB.

Omass

Oxford, GB · Founded 2016 · 75 employees on LinkedIn · 5 known investors

Find your way into Omass

575 people in our graph share verified history with the Omass team — schools, employers, funds. One of them is your warm intro.

Chris Bischoffunlockedknows Ros Deegan · together at INSEAD (overlapped)

knows the team · via INSEAD

×4knows the team · via KPMG

×3knows the team · via University of Cambridge

×2knows the team · via GSK

knows the team · via @10 Downing Street

OMass is a biotech company that originated as a spinout from Oxford University, developing specialized treatments for patient populations with high unmet medical needs. The company builds integrated development and commercialization capabilities while partnering to advance programs addressing large indications.

Biotech Deep Tech Digital Health Healthtech Medical Devices

Founders & leadership

Omass was founded in 2016 by Professor Dame Carol Robinson, Idlir Liko, Jonathan Hopper, and Hsin Yung (Jason) Yen.

Professor Dame Carol RobinsonFounder and Chair of Scientific Advisory Board

Idlir LikoinFounder

Jonathan HopperinVice President, Platforms and Founder

Hsin Yung (Jason) YeninFounder

Ros Deegan inCEORos Deegan has 20 years of biotech and pharmaceutical industry experience, including business development roles at Bicycle Therapeutics, Trevena, and GSK. She holds an MBA from INSEAD and a first-class degree from Cambridge University.

Investors · 5

GV (Google Ventures)✓ verifiedMountain View · $250K – $50M

Oxford Science Enterprises✓ verifiedOxford · $63.5K – $31.8M

Sanofi Ventures✓ verifiedCambridge · $5M

Syncona✓ verifiedLondon

Northpond Ventures✓ verifiedBethesda · $100K – $5M

Frequently asked questions

What does Omass do?: OMass is a biotech company that originated as a spinout from Oxford University, developing specialized treatments for patient populations with high unmet medical needs. The company builds integrated development and commercialization capabilities while partnering to advance programs addressing large indications.
Who founded Omass?: Omass was founded by Professor Dame Carol Robinson, Idlir Liko, Jonathan Hopper, Hsin Yung (Jason) Yen in 2016.
Who are Omass's investors?: Omass's investors include GV (Google Ventures), Oxford Science Enterprises, Sanofi Ventures, Syncona, Northpond Ventures.
Where is Omass headquartered?: Omass is headquartered in Oxford, GB.